Alveolar Ridge Preservation Following Tooth Extraction.
NCT ID: NCT05505084
Last Updated: 2025-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
50 participants
OBSERVATIONAL
2022-08-15
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In general, the membrane serves the function of the barrier and space protector. The periodontal surgeon use membranes to exclude the epithelium growth and to limit the collapse of the soft tissue into the healing alveolar socket. Regarding resorbable and non-resorbable membrane materials, both serve the function of protecting the graft material from the oral cavity. However, there are also many demonstrating that without membranes the extraction socket healed nicely without any interferences. The question to us is: Do we need the membrane to exclude the epithelium or any kind of surgical dressing material is sufficient enough to preserve the volume of the extracted ridge?
The object of this study is to compare five popular membranes on the market that present different characteristics of the membranes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Alveolar Ridge Preservation After Tooth Extraction in the Posterior Maxilla
NCT02952209
Site Preservation After Tooth Extraction
NCT05258019
Alveolar Ridge Changes With Biologically Oriented Alveolar Ridge Preservation (BARP) After Tooth Extraction
NCT05553548
Alveolar Ridge Preservation After Tooth Extraction Using Autologous Dentin Matrix
NCT06541236
Ridge Preservation Following Tooth Extraction
NCT05485194
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The following products will be used during the study:
* Collatape (Zimmer Dental)- approved by the FDA (class III)
* Cytoplast (Osteogenics Biomedical)- cleared by the FDA
* OssixPlus (Dantum Dental)- cleared by the FDA
* Renovix-Plus (Salvin)- cleared by the FDA
* BioXclude (SNOASIS)-certificate from the American Association of Tissue Banking
* PuroⓇ, Zimmer Dental)- cleared by the FDA
* RegenerOssⓇ, Zimmer Dental) - cleared by the FDA
During the appointment for the implant placement. A bone core from all subjects in each treatment group will be collected from the augmentation site instead of drilling away. The sample will be evaluated for the following:
* % viable of bone
* % of connective tissue
* % of residual graft material
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Collatape (Zimmer Dental)
This material is a resorbable collagen wound dressing. They are made from bovine Achilles tendons and are a source of Type I collagen. The resorbable wound dressings are sterilized after purification with ethylene oxide.
Tooth extraction and ridge preservation using different barrier mermbranes
The hopeless and unrestorable teeth are planned for extraction and implant placement.
Cytoplast Barrier Membranes TXT-200 Singles (Osteogenics Biomedical)
Cytoplast Barrier membranes are manufactured from high-density Polytetrafluoroethylene (PTFE) which allows them to withstand exposure to the oral environment. The textured surface increases the surface area available for cellular attachment during dental bone grafting procedures thereby aiding in stabilizing the PTFE membrane. It can be removed non-surgically after at least 21 days.
Tooth extraction and ridge preservation using different barrier mermbranes
The hopeless and unrestorable teeth are planned for extraction and implant placement.
Ossix Plus (dantum dental)
OssixPlus is a resorbable collagen dental membrane used for Guided Bone Regeneration and Guided Tissue Regeneration. It contains a patented GLYMATRIX cross-linking technology that allows it to maintain barrier functionality for 4 to 6 months. The collagen is derived from porcine.
Tooth extraction and ridge preservation using different barrier mermbranes
The hopeless and unrestorable teeth are planned for extraction and implant placement.
Renovix-Plus (Salvin)
Renovix Plus is a non-cross-linked extracellular matrix containing Type I, II, and III Collagen, Fibronectin, Laminin, and Elastin. It provides architecture and barrier protection for bone regeneration and soft tissue esthetics. This membrane resorbs within six months.
Tooth extraction and ridge preservation using different barrier mermbranes
The hopeless and unrestorable teeth are planned for extraction and implant placement.
BioXclude (Snoasis)
BioXclude is a minimally manipulated allograft amnion chorion tissue. It is obtained from consenting mothers who donate their placentas after elective caesarian section delivery. The tissue is processed to cleanse and maintain the tissue. Following processing and dehydration, the allografts are packaged and terminally sterilized.
Tooth extraction and ridge preservation using different barrier mermbranes
The hopeless and unrestorable teeth are planned for extraction and implant placement.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tooth extraction and ridge preservation using different barrier mermbranes
The hopeless and unrestorable teeth are planned for extraction and implant placement.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects must require removal of at least one maxillary premolar
* Subjects should benefit from an implant-supported crown.
* Subjects must have voluntarily signed the informed consent form.
* Subjects must be assessed as ASA I, ASA II by a member of the research team.
Exclusion Criteria
* History of leukocyte dysfunction or deficiencies, bleeding deficiencies, renal failure, uncontrolled endocrine disorders, acquired immunodeficiency syndrome or hepatitis.
* History of neoplastic disease requiring the use of chemotherapy or irradiation to head and neck.
* Subjects who have diabetes mellitus.
* Subjects who have undergone administration of any investigational drug or device within 30 days of enrollment in the study.
* Alcohol or drug abuse.
* Subjects who are heavy smokers (greater than 10 cigarettes per day or cigar equivalents) or chew tobacco.
* Conditions or circumstances, in the opinion of the research team, which would prevent completion of study participation or interfere with analysis of study results, such as a history of non-compliance or unreliability.
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ZimVie
INDUSTRY
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yucheng Chang
Director of Predoctoral Periodontics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yu-Cheng Chang, DMD
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Penn Dental Medicine
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lekovic V, Kenney EB, Weinlaender M, Han T, Klokkevold P, Nedic M, Orsini M. A bone regenerative approach to alveolar ridge maintenance following tooth extraction. Report of 10 cases. J Periodontol. 1997 Jun;68(6):563-70. doi: 10.1902/jop.1997.68.6.563.
Ismail NM, Mustapha MS, Megat R. The subcellular localisation and the time course of bismuth in the gastric mucosa of rats after short-term administration of colloidal bismuth subcitrate. Ann Acad Med Singap. 1997 Nov;26(6):754-7.
Tan WL, Wong TL, Wong MC, Lang NP. A systematic review of post-extractional alveolar hard and soft tissue dimensional changes in humans. Clin Oral Implants Res. 2012 Feb;23 Suppl 5:1-21. doi: 10.1111/j.1600-0501.2011.02375.x.
Van der Weijden F, Dell'Acqua F, Slot DE. Alveolar bone dimensional changes of post-extraction sockets in humans: a systematic review. J Clin Periodontol. 2009 Dec;36(12):1048-58. doi: 10.1111/j.1600-051X.2009.01482.x.
Misawa M, Lindhe J, Araujo MG. The alveolar process following single-tooth extraction: a study of maxillary incisor and premolar sites in man. Clin Oral Implants Res. 2016 Jul;27(7):884-9. doi: 10.1111/clr.12710. Epub 2015 Nov 14.
Avila-Ortiz G, Elangovan S, Kramer KW, Blanchette D, Dawson DV. Effect of alveolar ridge preservation after tooth extraction: a systematic review and meta-analysis. J Dent Res. 2014 Oct;93(10):950-8. doi: 10.1177/0022034514541127. Epub 2014 Jun 25.
Corbella S, Taschieri S, Francetti L, Weinstein R, Del Fabbro M. Histomorphometric Results After Postextraction Socket Healing with Different Biomaterials: A Systematic Review of the Literature and Meta-Analysis. Int J Oral Maxillofac Implants. 2017 September/October;32(5):1001-1017. doi: 10.11607/jomi.5263. Epub 2017 Feb 23.
Jung RE, Ioannidis A, Hammerle CHF, Thoma DS. Alveolar ridge preservation in the esthetic zone. Periodontol 2000. 2018 Jun;77(1):165-175. doi: 10.1111/prd.12209. Epub 2018 Feb 27.
Bassir SH, Alhareky M, Wangsrimongkol B, Jia Y, Karimbux N. Systematic Review and Meta-Analysis of Hard Tissue Outcomes of Alveolar Ridge Preservation. Int J Oral Maxillofac Implants. 2018 Sep/Oct;33(5):979-994. doi: 10.11607/jomi.6399.
Avila-Ortiz G, Gubler M, Romero-Bustillos M, Nicholas CL, Zimmerman MB, Barwacz CA. Efficacy of Alveolar Ridge Preservation: A Randomized Controlled Trial. J Dent Res. 2020 Apr;99(4):402-409. doi: 10.1177/0022034520905660. Epub 2020 Feb 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
828879
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.